Poster Session 1.I - Theoretical and Translational Medicine
Fülöp, Ágnes
V0IZY8
Semmelweis University, Institute of Clinical Pathophysiology
+36305808606
fulop.agnes@semmelweis.hu
Pretreating Aged Mouse Hearts with the NAD⁺ Precursor NMN Confers Cardioprotective Benefits
Ágnes Fülöp1, Vanessza Yit Sokpanya2, Anna Csiszár3, Zoltán Ungvári4, Zoltán Benyó1, Zsuzsanna Miklós5
1: 1 Institute of Clinical Pathophysiology, Semmelweis University, Budapest, Hungary 2 HUN-REN-SU Cerebrovascular and Neurocognitive Diseases Research Group, Budapest, Hungary
2: 1 Institute of Clinical Pathophysiology, Semmelweis University, Budapest, Hungary
3: 3 Vascular Cognitive Impairment, Neurodegeneration and Healthy Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA 4 Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA 5 The Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA 6 International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Institute for Translational Medicine, Semmelweis University, Budapest, Hungary
4: 3 Vascular Cognitive Impairment, Neurodegeneration and Healthy Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA 4 Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA 6 International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Institute for Translational Medicine, Semmelweis University, Budapest, Hungary 7 Fodor Center for Prevention and Healthy Aging, Semmelweis University, Budapest, Hungary
5: 1 Institute of Clinical Pathophysiology, Semmelweis University, Budapest, Hungary 8 National Korányi Institute for Pulmonology, Budapest, Hungary
Poszter
Poster Session 1.I - Theoretical and Translational Medicine
English
Theoretical and Translational Medicine
During aging, nicotinamide adenine dinucleotide (NAD+) depletion and impairment of cardiac ischemia tolerance can develop.
Our aim was to explore whether treatment with NAD+ precursor (nicotinamide mononucleotide, NMN) improves heart function and prevents enhanced ischemic damage in old hearts.
After pretreatment of young and old (4 and 26 months old) C57Bl/6N male mice with NMN (500 mg/kg/day ip.) or carrier (PBS) for 2 weeks, echocardiographic examination was performed. Afterwards, hearts were isolated and perfused with constant pressure in a Langendorff system. The hearts were exposed to 23 minutes of global ischemia, followed by a 120-minute reperfusion period. Coronary flow and left ventricular (LV) pressure changes were measured, and LV infarct size was determined.
In elderly hearts, echocardiography showed enlargement of the left ventricle, however ejection fraction was preserved. NMN treatment did not affect the echocardiographic parameters. The ratio of the infarcted area in LV of old mice was significantly higher compared to the young mice. After NMN pretreatment, the myocardial infarction size of the old hearts decreased. The postischemic coronary flow and functional restitution of old hearts were impaired compared to young controls, however NMN treatment restored this impairment.
Pretreatment with NAD+ precursor does not affect the resting heart function, whereas it significantly reduces the consequences of cardiac ischemia in hearts of aged mice; it has a favorable effect both on infarct size and on postischemic functional recovery.
Funding: NRDIO K-125174, K-139230, K151053; ÚNKP-22-4-II-SE-17; RRF-2.1.2.-12-2022-0001; TKP2021-EGA-25; R01AG055395, R01AG068295, R01AG070915, R01NS100782, R01CA255840.
Semmelweis University
Prof. Dr. Zoltán Benyó and Dr. Zsuzsanna Miklós
I do not give consent to the publication of my abstract on the website of the congress.
in doctoral studies after complex exam (PhD)
Szabad
elfogadva
poszter
nem rendelkezett róla
7514
17:42
17:45